| Drug
Name |
BNF |
Indication |
Originator |
| (Sort) |
(Sort) |
|
|
| Anastrozole |
8.3.4.1 |
Postmenopausal breast cancer |
MTRAC |
| Risperidone IM |
4.2.1 |
Schizophrenia |
MTRAC |
| Latanoprost |
11.6 |
Open angle glaucoma/Ocular hypertension |
MTRAC |
| Bimatoprost |
11.6 |
Open angle glaucoma/Ocular hypertension |
MTRAC |
| Cilostazol |
2.6.4.1 |
Intermittent claudication |
MTRAC |
| Travoprost |
11.6 |
Open angle glaucoma/Ocular hypertension |
MTRAC |
| Lamivudine |
5.3 |
Chronic hepatitis B |
MTRAC |
| Adefovir |
5.3 |
Chronic hepatitis B |
MTRAC |
| Ropinirole |
4.9.1 |
Parkinson's disease |
MTRAC |
| Entacapone |
4.9.1 |
Parkinson's disease |
MTRAC |
| Cabergoline |
4.9.1 |
Parkinson's disease |
MTRAC |
| Levetiracetam |
4.8.1 |
Partial seizure epilepsy |
MTRAC |
| Sevelamer |
9.5.2.2 |
Hyperphosphataemia |
MTRAC |
| Tobramycin nebuliser |
5.1.4 |
Cystic fibrosis |
MTRAC |
| Pramipexole |
4.9.1 |
Parkinson's disease |
MTRAC |
| Low molecular weight heparin |
2.8.1 |
Extended surgical prophylaxis |
MTRAC |
| Dalteparin sodium |
2.8.1 |
Extended surgical prophylaxis |
MTRAC |
| Exemestane |
8.3.4.1 |
Advanced breast cancer |
MTRAC |
| Darbepoetin alfa |
9.1.3 |
Anaemia of chronic renal failure |
MTRAC |
| Cyproterone acetate |
8.3.4.2 |
Prostate cancer |
MTRAC |
| Carvedilol |
2.4 |
Chronic heart failure |
MTRAC |
| Bicalutamide |
8.3.4.2 |
Advanced prostate cancer |
MTRAC |
| Galantamine |
4.11 |
Alzheimer's disease |
North Derbyshire Health PACE |
| Methylphenidate |
4.4 |
ADHD |
North Derbyshire Health PACE |
| Dornase alfa |
3.7 |
Cystic fibrosis |
North Derbyshire Health PACE |
| Apomorphine |
4.9.1 |
Parkinson's disease |
North Derbyshire Health PACE |
| Fentanyl lozenges |
4.7.2 |
Opiod breakthrough pain |
North Derbyshire Health PACE |
| Exemestane |
8.3.4.1 |
Advanced breast cancer |
North Derbyshire Health PACE |
| Rivastigmine |
4.11 |
Alzheimer's disease |
North Derbyshire Health PACE |
| Donepezil |
4.11 |
Alzheimer's disease |
North Derbyshire Health PACE |
| Anastrozole |
8.3.4.1 |
Advanced breast cancer |
North Derbyshire Health PACE |
| Olanzapine |
4.2.1 |
Schizophrenia |
North Nottinghamshire Prescribing Strategy Group |
| Pramipexole |
4.9.1 |
Parkinson's disease |
North Nottinghamshire Prescribing Strategy Group |
| Sulfasalazine |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Pergolide |
4.9.1 |
Parkinson's disease |
North Nottinghamshire Prescribing Strategy Group |
| Cabergoline |
4.9.1 |
Parkinson's disease |
North Nottinghamshire Prescribing Strategy Group |
| Dopamine agonists |
4.9.1 |
Parkinson's disease |
North Nottinghamshire Prescribing Strategy Group |
| Risperidone |
4.2.1 |
Schizophrenia |
North Nottinghamshire Prescribing Strategy Group |
| Ropinirole |
4.9.1 |
Parkinson's disease |
North Nottinghamshire Prescribing Strategy Group |
| Antipsychotics-atypical |
4.2.1 |
Schizophrenia |
North Nottinghamshire Prescribing Strategy Group |
| Penicillamine |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Quetiapine |
4.2.1 |
Schizophrenia |
North Nottinghamshire Prescribing Strategy Group |
| Methotrexate |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Leflunomide |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Hydroxychloroquine |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Ciclosporin |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Azathioprine |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Aurothiomalate sodium |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Antirheumatic agents |
10.1.3 |
Rheumatoid arthritis |
North Nottinghamshire Prescribing Strategy Group |
| Amisulpride |
4.2.1 |
Schizophrenia |
North Nottinghamshire Prescribing Strategy Group |
| Riluzole |
4.9.3 |
Amyotrophic lateral sclerosis (ALS) |
Southern Derbyshire |
| Anastrozole |
8.3.4.1 |
Advanced breast cancer |
Walsall Manor Hospital NHS Trust |
| Methotrexate |
10.1.3 |
Rheumatoid arthritis |
Walsall Manor Hospital NHS Trust |
| Letrozole |
8.3.4.1 |
Advanced breast cancer |
Walsall Manor Hospital NHS Trust |
| LHRH analogues |
6.7.2 |
Endometriosis |
Walsall Manor Hospital NHS Trust |
| Goserelin |
6.7.2 |
Endometriosis |
Walsall Manor Hospital NHS Trust |
| Nafarelin |
6.7.2 |
Endometriosis |
Walsall Manor Hospital NHS Trust |
| Buserelin |
6.7.2 |
Endometriosis |
Walsall Manor Hospital NHS Trust |
| Methylphenidate |
4.4 |
ADHD |
Walsall Manor Hospital NHS Trust |
| Leuprorelin |
6.7.2 |
Endometriosis |
Walsall Manor Hospital NHS Trust |
| Leflunomide |
10.01.03 |
Rheumatoid Arthritis |
West Midlands Chief Pharmacists |
format please
select the 'Drug Name' to view.